United States Últimas notícias

Pediatrix Medical Group (NYSE:MD) reported third-quarter 2026 revenue of $501.4 million, up 1.7% year over year, with net income of $47 million.

Linde (NASDAQ:LIN) reported third-quarter 2026 sales of $9.404 billion, up 9% year over year, while adjusted diluted earnings per share increased 9% to $4.59.

Anna Edwards, Tom Mackenzie and Paul Dobson break down today's key themes for analysts and investors on "Bloomberg: The Opening Trade."

TotalEnergies (NYSE:TTE) reported third-quarter 2026 adjusted net income of $9.1 billion, up 51% from the previous quarter as higher gas prices and refining margins supported earnings.

TAL Education (NYSE:TAL) reported fiscal second-quarter 2027 revenue of US$994.6 million, up 15.5% year over year, while operating income rose 145.4% to US$235.9 million.

Portland General Electric (NYSE:POR) reported third-quarter adjusted earnings of $1.06 per diluted share and revised its 2026 adjusted earnings guidance to $3.18–$3.28 per share.

HUTCHMED (NASDAQ:HCM) received US Food and Drug Administration Orphan Drug Designation for sovleplenib to treat primary immune thrombocytopenia, an autoimmune disorder that increases bleeding risk.

California Water Service Group (NYSE:CWT) reported third-quarter 2026 revenue of $332.2 million, up 6.7% year over year, while net income increased to $65.4 million.

Fiverr (NYSE:FVRR) reported third-quarter 2026 revenue of $90.9 million, down 15.8% year over year, and raised its full-year financial guidance ranges.

ING (NYSE:ING) reported third-quarter 2026 net result of €1.850 billion, up 3.5% year over year, as profit before tax increased 5.7% to €2.705 billion.

Molecular Partners (NASDAQ:MOLN) plans to reduce its workforce by up to approximately 44%, affecting no more than 55 positions, as it increases its focus on targeted radiotherapy.

STMicroelectronics (NYSE:STM) reported third-quarter 2026 revenue of $3.76 billion, up 17.9% year over year, as operating income increased to $367 million.